July 26, 2018
Proteus Digital Health’ pitch to track adherence using sensor-equipped pills has found another audience in the HIV prevention community.
Among the featured data presented at this week’s International AIDS Conference in Amsterdam was a trial that outfitted Gilead Sciences’ preventive HIV drug Truvada (tenofovir/emtricitabine) with the tracking technology. Here, researchers found that the sensor-...
March 8, 2018
It’s still the early days, but the FDA’s approval of Proteus Digital Health and Otsuka Pharmaceuticals’ Abilify MyCite has changed the discussion of digital technology in healthcare. The first approval of drug delivery via a sensor-equipped pill sparked debates over the tradeoff of privacy for medication adherence, and whether these types of technologies would find a role in future healthcare....
November 14, 2017
The first drug in the US with a digital ingestion tracking system has been approved by the FDA.
The pill, Abilify MyCite, is prescribed for treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and as an add-on treatment for depression in adults.
An ingestible sensor embedded in the pill is able to record that the medication was taken – sending...
June 13, 2016
Digital health and digital therapeutics will produce a tremendous amount of data, which could be the key to getting them reimbursed by payers, according to panelists at BIO 2016 last week. UCSF Professor of Health Economics and Health Services Research Kathryn Phillips led a panel that included Rowan Chapman, managing director of new business ventures at GE Ventures; Evidation Health CEO Deborah...
April 27, 2016
The FDA declined to approve what would have been the first mass market drug to incorporate Proteus Digital Health's ingestible sensor. The drug, a collaboration between Proteus and Otsuka Pharmaceuticals, combines the Proteus system with the antipsychotic pharmaceutical Abilify.
“While we are disappointed in the FDA’s decision not to approve this digital medicine at this time, both Otsuka and...
January 12, 2016
When Proteus Digital Health got its first FDA clearance, Stephen Colbert, then still the host of The Colbert Report, featured the pill on his ‘Cheating Death’ segment.
“The sensor can help patients suffering from diseases of the central nervous center, including schizophrenia,” he said. “Because nothing is more reassuring to a schizophrenic than a corporation inserting sensors into your body that...
November 17, 2015
Proteus Digital Health, which offers an ingestible sensor and digital medicine system, has hired Molly O’Neill as its chief commercial officer. O'Neill previously served as SVP of business development at Tenet Health, a healthcare services company. Before working at Tenet, O'Neill worked at Ascension Health Care Network, Inova Health System, and Duke University Health System. At Proteus, O'Neill...
July 2, 2015
Proteus Digital Health has received an update to its FDA 510(k) clearance for its digital medicine platform, adding a new indication to the clearance. The system is now, to the company’s knowledge, the first technology to have an indication in its FDA clearance for measuring medication adherence.
“We are delighted that our collaborative work with the FDA continues to enable positive progress,”...
January 5, 2015
Funding by category, from Rock Health's report
Seed investor Rock Health and digital health academy StartUp Health, two companies that track funding and other data points about digital health, are both reporting 2014 as a record-breaking funding year for digital health in multiple categories.
Rock Health places the total digital health funding for 2014 just over $4 billion, while StartUp...
January 18, 2013
Care4Today by Janssen Healthcare Innovation
For one reason or another, as many as half the patients in the United States don't take the medication that is prescribed to them at a cost to the US healthcare system of $290 billion a year in waste. That's according to NEHI, formerly known as the New England Healthcare Institute, which has been tracking the medication adherence problem for years....